In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
DENTSPLY Sirona Inc (NASDAQ: XRAY) closed the day trading at $13.87 up 0.14% from the previous closing price of $13.85. In other words, the price has increased by $0.14 from its previous closing price. On the day, 3.93 million shares were traded. XRAY stock price reached its highest trading level at $13.885 during the session, while it also had its lowest trading level at $13.38.
Ratios:
For a better understanding of XRAY, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.71 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 20.05. For the most recent quarter (mrq), Quick Ratio is recorded 1.11 and its Current Ratio is at 1.69. In the meantime, Its Debt-to-Equity ratio is 1.27 whereas as Long-Term Debt/Eq ratio is at 1.18.
On February 14, 2025, Wells Fargo started tracking the stock assigning a Equal Weight rating and target price of $20.Wells Fargo initiated its Equal Weight rating on February 14, 2025, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 03 ’25 when LUCIER GREGORY T bought 15,142 shares for $16.51 per share. The transaction valued at 249,994 led to the insider holds 81,971 shares of the business.
Coleman Glenn bought 15,759 shares of XRAY for $311,240 on Jan 27 ’25. On Nov 18 ’24, another insider, LUCIER GREGORY T, who serves as the Director of the company, bought 5,000 shares for $18.37 each. As a result, the insider paid 91,850 and bolstered with 71,730 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XRAY now has a Market Capitalization of 2766843136 and an Enterprise Value of 4917841408. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.75 while its Price-to-Book (P/B) ratio in mrq is 1.41. Its current Enterprise Value per Revenue stands at 1.34 whereas that against EBITDA is 7.856.
Stock Price History:
The Beta on a monthly basis for XRAY is 0.97, which has changed by -0.45629168 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, XRAY has reached a high of $27.48, while it has fallen to a 52-week low of $12.16. The 50-Day Moving Average of the stock is -10.55%, while the 200-Day Moving Average is calculated to be -18.18%.
Shares Statistics:
Over the past 3-months, XRAY traded about 2.99M shares per day on average, while over the past 10 days, XRAY traded about 5259760 shares per day. A total of 199.30M shares are outstanding, with a floating share count of 198.21M. Insiders hold about 0.64% of the company’s shares, while institutions hold 100.84% stake in the company. Shares short for XRAY as of 1753920000 were 7176058 with a Short Ratio of 2.40, compared to 1751241600 on 7888793. Therefore, it implies a Short% of Shares Outstanding of 7176058 and a Short% of Float of 4.01.
Dividends & Splits
XRAY’s forward annual dividend rate is 0.64, up from 0.64 a year ago. Against a Trailing Annual Dividend Yield of 0.046209384The stock’s 5-year Average Dividend Yield is 1.69.
